Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 22.28
-0.50 (-2.19%)
Oct 1, 2026, 3:29 PM IST
Balaxi Pharmaceuticals Market Cap
Balaxi Pharmaceuticals has a market cap or net worth of 1.23 billion as of October 1, 2026. Its market cap has decreased by -48.81% in one year.
Market Cap
1.23B
Enterprise Value
1.64B
Revenue
2.80B
Ranking
n/a
PE Ratio
49.96
Stock Price
22.28
ChartMarket Cap Chart
Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 1.23B, an increase of 2,872.18%. That is a compound annual growth rate of 36.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 1.23B | -16.86% |
| Dec 31, 2025 | 1.48B | -59.70% |
| Dec 31, 2024 | 3.68B | -16.38% |
| Dec 29, 2023 | 4.40B | -27.68% |
| Dec 30, 2022 | 6.09B | 18.63% |
| Dec 31, 2021 | 5.13B | -21.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 10.99B |
| Bafna Pharmaceuticals | 8.78B |
| Amanta Healthcare | 7.39B |
| Valiant Laboratories | 6.64B |
| Nectar Lifesciences | 2.08B |
| Brooks Laboratories | 1.66B |
| Par Drugs and Chemicals | 1.54B |
| Alpa Laboratories | 1.26B |